. 2015 Oct 14;15:419. doi: 10.1186/s12879-015-1147-x

Table 2.

Prevalence of PCV13 serotypes in Western European countries in children <5 years of age. For details on local vaccine use, please see text

	Age (year)	Post-PCV7 period		Three most prevalent serotypes	Post-higher valent PCV periods		Three most prevalent serotypes
	Age (year)	Year	Among all IPD, %	Three most prevalent serotypes	Year	Among all IPD, %	Three most prevalent serotypes
Countries in which only PCV13 used
Belgium [11]	<5	2010	73	19A, 1, 7 F	2013	36	1, 12 F, 24 F
France [20]	<2	2009	71	19A, 7 F, 1	2012	24	24 F, 12 F, 15B/C
Italy [24]	<5	2011	64	1, 19A, 22 F	2014	37	19A, 1, 24 F
Norway [25]	<5	2010	61	19A, 1, 7 F	2012	26	1, 15B/C
Switzerland [29]	<2	2010–2011	68	3, 19A, 7 F	2012	53	3, 23 (not 23 F), 19 F
UK [31]	<5	2008–2010	68	7 F, 19A, 1	2013–2014	15	24 F, 22 F, 33 F
Countries in which only PCV10 used
Austria [33, 37]	<5	2009	73	3, 14, 18C	2013	93	19A, 7 F, 23 F
Finland [39]	<5	2010	92	14, 6B, 19 F	2014	70	19A, 3, 7 F, 23A
Countries in which both PCV13 and PCV10 used
Germany^a [44]	<16	2008–2009	56	7 F, 1, 18C^b	2012–2013	12	7 F, 10A, 19A^c
Sweden [45]	<2	2009	84	22 F, 7 F, 3, 19A	2012	47	33 F, 11

^aPneumococcal meningitis; ^b2007–2010; ^c2010–2013